About Rimegepant API
Therapeutic CategoryCentral Nervous System (CNS)

CAS Number
929046-33-3
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Under Development
Mechanism of Action
Rimegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking CGRP receptors, which helps to reduce migraine symptoms by preventing the amplification and perpetuation of migraine pain
Indication
Xanomeline is indicated for the treatment of schizophrenia